ArticleInternational journal of nanomedicine2022
Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction].
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.